How do I get Wegovy in the UK?

You've decided to look into it, here's the fork in the road

Picture where most people land: you've done your research, your BMI qualifies on paper, and you want to know whether Wegovy is something you could actually start. The honest answer is that the starting point is identical whichever route you take, a prescriber has to assess you. What differs is the waiting time, the setting, and the criteria applied.

On the NHS, Wegovy is available through specialist weight management services under NICE's recommendation for semaglutide (TA875). To be considered, you generally need a BMI of 35 or above alongside at least one weight-related condition, and you must be seen within a multidisciplinary service that includes diet and activity support. The NICE recommendation also carries a two-year maximum treatment duration under NHS commissioning. Waiting lists for these services are long in most parts of England, and access varies considerably by region. If you want to understand more about how semaglutide works before committing to either route, our semaglutide overview covers the pharmacology and evidence in plain language.

The private route through a regulated online pharmacy has different eligibility thresholds (closer to the licensed indication in the product's SmPC) so some people who fall short of NHS criteria can still be assessed privately. A BMI of 30 or above, or 27 to 29.9 with a relevant condition such as high blood pressure, type 2 diabetes or obstructive sleep apnoea, is the private benchmark. If you are wondering how to get semaglutide, our dedicated page walks through the practical steps and what to expect from the process. That said, BMI alone is never the whole picture; a prescriber looks at your full health history before deciding.

What the private online pharmacy process involves from your side

Once you decide to go the private route, the process is more straightforward than many people expect, but it is not a formality. At nume, you start with a free consultation. A GPhC-registered Independent Prescriber reads your answers personally, the same day; it is a real clinician, not an automated screening tool. If you order before 12pm Monday to Friday and your prescription is approved as clinically suitable, your treatment is dispatched the same day by DPD and arrives the next working day in plain, unbranded packaging.

Identity and weight are verified (photo ID and live video confirmation) before any treatment is issued. This is not bureaucracy for its own sake; it is part of what makes a private prescription from a regulated pharmacy safe. Every repeat order goes through the same clinical review, with no automatic renewals. If you want the fuller picture of what is included in a private prescription service, the Wegovy treatment page sets it out clearly.

One practical check worth doing before you commit to any provider: visit the GPhC pharmacy register and search the name or registration number. It takes less than a minute and confirms whether you are dealing with a properly regulated pharmacy. Any seller offering Wegovy without asking for a prescription or clinical history is operating outside the law, and the MHRA has warned publicly about fake weight-loss pens sold online, some of which have been found to contain insulin.

NHS versus private: what genuinely differs

The NHS route, when accessible, carries no medicine cost to the patient and sits within a multidisciplinary team. The trade-off is the stricter NICE criteria and, in practice, the wait. If you want more detail on the NHS side of this, our page on getting Wegovy for weight loss walks through the NICE pathway and what NHS services typically involve.

The private route removes the waiting list and the referral requirement. The trade-off is the cost, which varies between providers. What a legitimate price always includes is the clinical assessment and the prescription, any quote that does not include those should raise questions. For context on how private Wegovy pricing is structured and what to watch for, the Wegovy where to buy page covers the market honestly.

If you are already on Wegovy through another provider and thinking about moving across, or if you have questions about stopping treatment, the guidance on coming off Wegovy is a useful read before making any changes, and any switch should be discussed with a prescriber rather than managed unilaterally. Semaglutide is a medicine with a titration schedule, and stopping or switching without clinical input carries avoidable risks.

Wegovy at higher doses: what changed in 2026

One thing that has shifted the picture recently is the MHRA's approval of a higher dose. In January 2026 the 7.2mg maintenance dose was introduced (initially as three 2.4mg pens per week) and on 14 April 2026 the MHRA approved a dedicated single-dose 7.2mg pre-filled pen, designed as a single weekly injection for adults with a BMI of 30 or above. Trial data reported an average weight reduction of around 20.7% over 72 weeks at the 7.2mg dose, bringing results closer to those seen with tirzepatide in head-to-head evidence. You can read more about the Wegovy programme, including the dose range and how titration works, on the weight loss treatments overview.

Whether the 7.2mg pen is the right option for any individual is a clinical decision; starting dose remains 0.25mg regardless, titrated upward by the prescriber. NHS England's guidance on weight management injections covers what wraparound support looks like alongside the medicine, which applies equally to NHS and private patients. When you are ready to take the next step, check your eligibility with our prescribers, the consultation is free, and there is no obligation to proceed.